vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and XBP Global Holdings, Inc. (XBP). Click either name above to swap in a different company.
XBP Global Holdings, Inc. is the larger business by last-quarter revenue ($152.4M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -200.7%, a 162.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -34.7%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
PRCT vs XBP — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $152.4M |
| Net Profit | $-31.6M | $-305.8M |
| Gross Margin | 64.9% | 21.7% |
| Operating Margin | -4.1% | -191.7% |
| Net Margin | -38.1% | -200.7% |
| Revenue YoY | 20.2% | -34.7% |
| Net Profit YoY | -27.9% | -980.1% |
| EPS (diluted) | $-0.56 | $-2.60 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | — | ||
| Q3 25 | $83.3M | $152.4M | ||
| Q2 25 | $79.2M | — | ||
| Q1 25 | $69.2M | — | ||
| Q4 24 | $68.2M | — | ||
| Q3 24 | $58.4M | $233.4M | ||
| Q2 24 | $53.4M | — |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | — | ||
| Q3 25 | $-21.4M | $-305.8M | ||
| Q2 25 | $-19.6M | — | ||
| Q1 25 | $-24.7M | — | ||
| Q4 24 | $-18.9M | — | ||
| Q3 24 | $-21.0M | $-28.3M | ||
| Q2 24 | $-25.6M | — |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | 21.7% | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | 18.9% | ||
| Q2 24 | 59.0% | — |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | — | ||
| Q3 25 | -27.8% | -191.7% | ||
| Q2 25 | -28.0% | — | ||
| Q1 25 | -39.7% | — | ||
| Q4 24 | -28.9% | — | ||
| Q3 24 | -38.4% | 0.9% | ||
| Q2 24 | -50.3% | — |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | — | ||
| Q3 25 | -25.7% | -200.7% | ||
| Q2 25 | -24.7% | — | ||
| Q1 25 | -35.8% | — | ||
| Q4 24 | -27.6% | — | ||
| Q3 24 | -35.9% | -12.1% | ||
| Q2 24 | -48.0% | — |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | — | ||
| Q3 25 | $-0.38 | $-2.60 | ||
| Q2 25 | $-0.35 | — | ||
| Q1 25 | $-0.45 | — | ||
| Q4 24 | $-0.34 | — | ||
| Q3 24 | $-0.40 | $-0.09 | ||
| Q2 24 | $-0.50 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $34.5M |
| Total DebtLower is stronger | $51.7M | $381.5M |
| Stockholders' EquityBook value | $347.7M | $130.5M |
| Total Assets | $487.1M | $947.9M |
| Debt / EquityLower = less leverage | 0.15× | 2.92× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | — | ||
| Q3 25 | $294.3M | $34.5M | ||
| Q2 25 | $302.7M | — | ||
| Q1 25 | $316.2M | — | ||
| Q4 24 | $333.7M | — | ||
| Q3 24 | $196.8M | $7.8M | ||
| Q2 24 | $214.1M | — |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | $381.5M | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | $31.5M | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | — | ||
| Q3 25 | $380.3M | $130.5M | ||
| Q2 25 | $385.8M | — | ||
| Q1 25 | $389.2M | — | ||
| Q4 24 | $402.2M | — | ||
| Q3 24 | $241.2M | $-1.3B | ||
| Q2 24 | $251.8M | — |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | — | ||
| Q3 25 | $511.5M | $947.9M | ||
| Q2 25 | $513.1M | — | ||
| Q1 25 | $519.4M | — | ||
| Q4 24 | $534.0M | — | ||
| Q3 24 | $374.1M | $99.6M | ||
| Q2 24 | $374.4M | — |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | 2.92× | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $13.9M |
| Free Cash FlowOCF − Capex | — | $10.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | — | ||
| Q3 25 | $-6.6M | $13.9M | ||
| Q2 25 | $-15.0M | — | ||
| Q1 25 | $-17.0M | — | ||
| Q4 24 | $-32.4M | — | ||
| Q3 24 | $-18.8M | $-1.5M | ||
| Q2 24 | $-15.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | — | ||
| Q3 25 | $-9.5M | $10.5M | ||
| Q2 25 | $-17.8M | — | ||
| Q1 25 | $-18.8M | — | ||
| Q4 24 | $-33.6M | — | ||
| Q3 24 | $-19.0M | $-6.1M | ||
| Q2 24 | $-16.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | — | ||
| Q3 25 | -11.4% | 6.9% | ||
| Q2 25 | -22.5% | — | ||
| Q1 25 | -27.2% | — | ||
| Q4 24 | -49.2% | — | ||
| Q3 24 | -32.6% | -2.6% | ||
| Q2 24 | -31.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | — | ||
| Q3 25 | 3.4% | 2.2% | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.7% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 0.4% | 2.0% | ||
| Q2 24 | 2.0% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
XBP
| Related And Non Related Party | $136.5M | 90% |
| Technology | $8.2M | 5% |
| Other | $5.7M | 4% |
| Deferred Revenue As Of July312025 | $1.9M | 1% |
